Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
ATTENTION AstraZeneca PLC Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
07:25am, Monday, 11'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible viola
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
12:00pm, Sunday, 10'th Nov 2024
NEW YORK , Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors are advised
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
12:54pm, Friday, 08'th Nov 2024
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans voted on abortion access.
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible violat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
12:00pm, Friday, 08'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are advised
AstraZeneca has explaining to do after £50 billion value hit
07:15am, Friday, 08'th Nov 2024
At the start of September when its share price was at an all-time high and it was comfortably the UK's largest company, AstraZeneca PLC (LSE:AZN) management might have been expecting a routine third-q
AstraZeneca hails positive phase III data for repurposed asthma treatment
02:54am, Friday, 08'th Nov 2024
AstraZeneca PLC (LSE:AZN) and Amgen Inc (NASDAQ:AMGN, ETR:AMG) have unviled positive results from their phase III WAYPOINT study, which tested the effectiveness of Tezspire (tezepelumab) in treating
Astrazeneca (AZN) Surpasses Market Returns: Some Facts Worth Knowing
07:15pm, Thursday, 07'th Nov 2024
Astrazeneca (AZN) reachead $64.69 at the closing of the latest trading day, reflecting a +1.32% change compared to its last close.
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible violat
AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)
12:13pm, Thursday, 07'th Nov 2024
AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy the stock as the big picture looks positive. The company's numbers were strong in H1 2024 and its earn
Unveiling Astrazeneca (AZN) Q3 Outlook: Wall Street Estimates for Key Metrics
10:20am, Thursday, 07'th Nov 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Astrazeneca (AZN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the
AstraZeneca's China challenges explained
07:24am, Thursday, 07'th Nov 2024
AstraZeneca PLC's (LSE:AZN) stock has suffered in recent days, losing 15% of its value as details emerged about ongoing investigations involving the company's operations in China. Shore Capital analy
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
04:00pm, Wednesday, 06'th Nov 2024
AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the company's top line.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
02:30pm, Wednesday, 06'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are advised
AstraZeneca: China's investigation into exec separate from medical insurance probe
09:02am, Wednesday, 06'th Nov 2024
AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive, Leon Wang, is separate from a large health insurance fraud case al
